A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux
- PMID: 28880991
- PMCID: PMC5710251
- DOI: 10.1001/jamaoto.2017.1454
A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux
Abstract
Importance: Laryngopharyngeal reflux (LPR) is a common disorder with protean manifestations in the head and neck. In this retrospective study, we report the efficacy of a wholly dietary approach using alkaline water, a plant-based, Mediterranean-style diet, and standard reflux precautions compared with that of the traditional treatment approach of proton pump inhibition (PPI) and standard reflux precautions.
Objective: To determine whether treatment with a diet-based approach with standard reflux precautions alone can improve symptoms of LPR compared with treatment with PPI and standard reflux precautions.
Design, setting, and participants: This was a retrospective medical chart review of 2 treatment cohorts. From 2010 to 2012, 85 patients with LPR that were treated with PPI and standard reflux precautions (PS) were identified. From 2013 to 2015, 99 patients treated with alkaline water (pH >8.0), 90% plant-based, Mediterranean-style diet, and standard reflux precautions (AMS) were identified. The outcome was based on change in Reflux Symptom Index (RSI).
Main outcomes and measures: Recorded change in the RSI after 6 weeks of treatment.
Results: Of the 184 patients identified in the PS and AMS cohorts, the median age of participants in each cohort was 60 years (95% CI, 18-82) and 57 years (95% CI, 18-93), respectively (47 [56.3%] and 61 [61.7%] were women, respectively). The percentage of patients achieving a clinically meaningful (≥6 points) reduction in RSI was 54.1% in PS-treated patients and 62.6% in AMS-treated patients (difference between the groups, 8.05; 95% CI, -5.74 to 22.76). The mean reduction in RSI was 27.2% for the PS group and 39.8% in the AMS group (difference, 12.10; 95% CI, 1.53 to 22.68).
Conclusions and relevance: Our data suggest that the effect of PPI on the RSI based on proportion reaching a 6-point reduction in RSI is not significantly better than that of alkaline water, a plant-based, Mediterranean-style diet, and standard reflux precautions, although the difference in the 2 treatments could be clinically meaningful in favor of the dietary approach. The percent reduction in RSI was significantly greater with the dietary approach. Because the relationship between percent change and response to treatment has not been studied, the clinical significance of this difference requires further study. Nevertheless, this study suggests that a plant-based diet and alkaline water should be considered in the treatment of LPR. This approach may effectively improve symptoms and could avoid the costs and adverse effects of pharmacological intervention as well as afford the additional health benefits associated with a healthy, plant-based diet.
Conflict of interest statement
Figures
Comment in
-
Dietary Modifications in the Treatment of Laryngopharyngeal Reflux-Will "an Apple a Day" Keep the Laryngopharyngeal Reflux Away?JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1030-1031. doi: 10.1001/jamaoto.2017.1449. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28880985 No abstract available.
Similar articles
-
Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.JAMA Otolaryngol Head Neck Surg. 2013 Dec;139(12):1291-5. doi: 10.1001/jamaoto.2013.5556. JAMA Otolaryngol Head Neck Surg. 2013. PMID: 24201320
-
Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.Eur Arch Otorhinolaryngol. 2018 Oct;275(10):2515-2521. doi: 10.1007/s00405-018-5079-0. Epub 2018 Jul 30. Eur Arch Otorhinolaryngol. 2018. PMID: 30062580
-
Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications.Ann Otol Rhinol Laryngol. 2011 May;120(5):281-7. doi: 10.1177/000348941112000501. Ann Otol Rhinol Laryngol. 2011. PMID: 21675582
-
A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3795-3801. doi: 10.1007/s00405-016-4142-y. Epub 2016 Jun 16. Eur Arch Otorhinolaryngol. 2016. PMID: 27312992 Review.
-
Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux.Braz J Med Biol Res. 2016 Jul 4;49(7):e5149. doi: 10.1590/1414-431X20165149. Braz J Med Biol Res. 2016. PMID: 27383119 Free PMC article. Review.
Cited by
-
Exploring the Substantive Significance of Laryngoscopic Observations as Reliable Prognostic Indicators for the Therapeutic Efficacy in Cases of Laryngopharyngeal Reflux.Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1660-1666. doi: 10.1007/s12070-023-04379-9. Epub 2023 Dec 12. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 38566637
-
Inhaled fosamprenavir for laryngopharyngeal reflux: Toxicology and fluid dynamics modeling.Laryngoscope Investig Otolaryngol. 2024 Jan 24;9(1):e1219. doi: 10.1002/lio2.1219. eCollection 2024 Feb. Laryngoscope Investig Otolaryngol. 2024. PMID: 38362183 Free PMC article.
-
The Impact of Nutrition on the Onset, Course of Disease and Quality of Life of Patients with Laryngopharyngeal Reflux.Food Technol Biotechnol. 2023 Dec;61(4):505-513. doi: 10.17113/ftb.61.04.23.8222. Food Technol Biotechnol. 2023. PMID: 38205049 Free PMC article.
-
Review article: Diagnosis and management of laryngopharyngeal reflux.Aliment Pharmacol Ther. 2024 Mar;59(5):616-631. doi: 10.1111/apt.17858. Epub 2024 Jan 8. Aliment Pharmacol Ther. 2024. PMID: 38192086 Review.
-
The Role of a Plant-Only (Vegan) Diet in Gastroesophageal Reflux Disease: Online Survey of the Italian General Population.Nutrients. 2023 Nov 8;15(22):4725. doi: 10.3390/nu15224725. Nutrients. 2023. PMID: 38004119 Free PMC article.
References
-
- Karkos PD, Wilson JA. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope. 2006;116(1):144-148. - PubMed
-
- Francis DO, Rymer JA, Slaughter JC, et al. . High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108(6):905-911. - PubMed
-
- Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011;56(4):931-950. - PubMed
-
- Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117(6):1036-1039. - PubMed
-
- Koufman JA, Johnston N. Potential benefits of pH 8.8 alkaline drinking water as an adjunct in the treatment of reflux disease. Ann Otol Rhinol Laryngol. 2012;121(7):431-434. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
